In an age-adjusted analysis, transgender individuals exhibited higher risk for chronic joint disorders when compared with cisgender individuals.

Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products.

Age and hypertension are associated with increased risks for cranial ischemic complications in GCA, while anticoagulant therapy may offer protective benefits.

Achievement of cancer remission was associated with dermatomyositis complete clinical response among patients with cancer-associated DM.

U.S. high school students do not engage in adequate levels of healthy dietary, physical activity, and sleep behaviors.

According to a recent study, tea consumption offers protective effects on mortality among patients with chronic kidney disease.

A significant reduction in the prevalence of episiotomy has not been followed by an overall increase in obstetric anal sphincter injury.

A significant percentage of patients with Lyme arthritis and other Lyme disease manifestations were positive for anti-RA33 antibodies.

The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.

Primary ovarian insufficiency was associated with a higher risk for autoimmune conditions including hypothyroidism and adrenal insufficiency.

For individuals reporting cannabis use, the odds of opioid misuse are reduced among individuals in states with medical cannabis legalization.

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...